Amkor Technology
AMKR · NasdaqSemiconductors & Related Devices · Fiscal year ends Dec 31
Amkor Technology reported revenue of $6.7B in the fiscal year ended Dec 2025, up 6.2% from the year before. Operating income was $467M, an operating margin of 7.0%, and net income was $374M. Operating cash flow of $1.1B less capital expenditure of $905M left free cash flow of $191M. Net debt was $67M.
Last 5 fiscal years
Revenue and net income
Income statement
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | $6.1B | $7.1B | $6.5B | $6.3B | $6.7B |
| Cost of revenue | $4.9B | $5.8B | $5.6B | $5.4B | $5.8B |
| Gross profit | $1.2B | $1.3B | $943M | $933M | $939M |
| Research & development | $166M | $149M | $177M | $163M | $167M |
| Selling, general & admin | $296M | $283M | $295M | $332M | $304M |
| Operating income | $763M | $897M | $470M | $438M | $467M |
| Interest expense | $52M | $59M | $59M | $65M | $75M |
| Pre-tax income | $715M | $857M | $444M | $431M | $445M |
| Income tax | $69M | $90M | $82M | $75M | $69M |
| Net income | $643M | $766M | $360M | $354M | $374M |
| Diluted EPS | 2.62 | 3.11 | 1.46 | 1.43 | 1.50 |
| Diluted shares | 246M | 246M | 247M | 248M | 248M |
Balance sheet
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Cash & equivalents | $827M | $959M | $1.1B | $1.1B | $1.4B |
| Receivables | $1.3B | $1.4B | $1.1B | $1.1B | $1.4B |
| Inventory | $485M | $630M | $393M | $311M | $438M |
| Current assets | $2.9B | $3.3B | $3.2B | $3.1B | $3.9B |
| Goodwill | $25M | $22M | $20M | $18M | $18M |
| Total assets | $6B | $6.8B | $6.8B | $6.9B | $8.1B |
| Payables | $829M | $899M | $754M | $713M | $913M |
| Deferred revenue | $118M | $81M | $71M | $60M | $70M |
| Current liabilities | $1.7B | $1.7B | $1.4B | $1.5B | $1.7B |
| Short-term debt | $153M | $144M | $132M | $236M | $162M |
| Long-term debt | $985M | $1.1B | $1.1B | $923M | $1.3B |
| Total liabilities | $3.1B | $3.1B | $2.8B | $2.8B | $3.6B |
| Shareholders' equity | $2.9B | $3.7B | $4B | $4.1B | $4.5B |
Cash flow
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating cash flow | $1.1B | $1.1B | $1.3B | $1.1B | $1.1B |
| Capital expenditure | $780M | $908M | $749M | $744M | $905M |
| Free cash flow | $342M | $190M | $521M | $345M | $191M |
| Depreciation & amortisation | $564M | $613M | $632M | $595M | $642M |
| Stock-based compensation | $11M | $14M | $8M | $18M | $20M |
| Dividends paid | $51M | $55M | $75M | $179M | $82M |
| Dividend per share | 0.17 | 0.23 | 0.30 | 0.72 | 0.33 |
Key ratios
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue growth (YoY) | – | 15.5% | −8.3% | −2.9% | 6.2% |
| Operating income growth (YoY) | – | 17.5% | −47.6% | −6.8% | 6.6% |
| EPS growth (YoY) | – | 18.7% | −53.1% | −2.1% | 4.9% |
| Gross margin | 20.0% | 18.8% | 14.5% | 14.8% | 14.0% |
| Operating margin | 12.4% | 12.7% | 7.2% | 6.9% | 7.0% |
| Net margin | 10.5% | 10.8% | 5.5% | 5.6% | 5.6% |
| Return on equityBlank when equity is negative | 21.9% | 20.9% | 9.1% | 8.5% | 8.4% |
| ROCEEBIT ÷ (assets − current liabilities) | 17.5% | 17.4% | 8.7% | 8.0% | 7.3% |
| Free cash flow margin | 5.6% | 2.7% | 8.0% | 5.5% | 2.8% |
| Cash conversion (CFO ÷ net income) | 1.74x | 1.43x | 3.53x | 3.08x | 2.93x |
| Receivable days | 75 | 70 | 65 | 61 | 74 |
| Inventory days | 36 | 40 | 26 | 21 | 28 |
| Payable days | 62 | 57 | 50 | 48 | 58 |
| Interest cover | 14.8x | 15.3x | 7.97x | 6.75x | 6.20x |
| Debt ÷ equity | 0.39x | 0.34x | 0.30x | 0.28x | 0.32x |
| Net debtDebt − cash & equivalents; excludes investments; negative = net cash | $311M | $273M | $84M | $26M | $67M |
| Current ratio | 1.70x | 1.99x | 2.31x | 2.11x | 2.27x |
Recent filings
More in Semiconductors & Related Devices
Standardised figures from the company's XBRL filings with the SEC (10-K, 10-Q). Line items follow US GAAP tags, so a company's own statement layout may differ and some lines show “–” where the company does not report that item. Ratios are calculated from these figures. For education only; not investment advice or a recommendation.